TCL Archive Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival September 28, 2012
TCL Archive Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA. May 16, 2008
TCL Archive NCI Plans to Fund FY 1985 R01s, P01s with Cuts 2.9-3.8% Under Recommended Groups, Centers Reduced 7-10% March 16, 1984